Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Upgraded to Strong-Buy at Hsbc Global Res

Hsbc Global Res upgraded shares of Bayer Aktiengesellschaft (OTCMKTS:BAYRY) from a hold rating to a strong-buy rating in a research report sent to investors on Wednesday,Zacks.com reports.

Several other research analysts have also recently weighed in on the stock. Kepler Capital Markets upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note on Wednesday. The Goldman Sachs Group upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 5th. Finally, Wall Street Zen upgraded shares of Bayer Aktiengesellschaft from a “hold” rating to a “buy” rating in a research note on Friday, June 6th. One equities research analyst has rated the stock with a hold rating, two have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Bayer Aktiengesellschaft presently has a consensus rating of “Buy”.

Bayer Aktiengesellschaft Trading Up 1.0%

Shares of BAYRY stock opened at $8.03 on Wednesday. Bayer Aktiengesellschaft has a 12-month low of $4.79 and a 12-month high of $8.58. The company has a current ratio of 1.32, a quick ratio of 0.81 and a debt-to-equity ratio of 1.19. The firm’s 50 day moving average is $6.62 and its 200 day moving average is $5.93. The stock has a market capitalization of $31.56 billion, a P/E ratio of -30.88 and a beta of 0.85.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) last issued its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The business had revenue of $15.27 billion for the quarter, compared to analysts’ expectations of $13.39 billion. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. Research analysts expect that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current year.

Bayer Aktiengesellschaft Increases Dividend

The company also recently announced a dividend, which was paid on Monday, May 12th. Investors of record on Wednesday, April 30th were paid a dividend of $0.0224 per share. This is a boost from Bayer Aktiengesellschaft’s previous dividend of $0.02. The ex-dividend date of this dividend was Tuesday, April 29th. This represents a dividend yield of 0.38%. Bayer Aktiengesellschaft’s payout ratio is -2.17%.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.